Delta sleep-inducing peptide, a nine-amino-acid peptide of uncertain endogenous role
PRODUCT PROFILE
DSIP
£13.99
DSIP is delta sleep-inducing peptide, a nine-amino-acid peptide of uncertain endogenous role. Researchers examine it in relation to sleep architecture, stress responses and neuroendocrine regulation.
Why it is distinct
Sleep is its historical research label, but mechanistic certainty is much lower than for receptor-defined peptides.
- Evidence stageEarly human evidence
- AvailabilityUnavailable
- Batch recordPublished after verification
- DispatchConfirmed at checkout
Out of stock
Ask about availabilityPRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
DSIP is delta sleep-inducing peptide, a nine-amino-acid peptide of uncertain endogenous role. Researchers examine it in relation to sleep architecture, stress responses and neuroendocrine regulation.
Research focus+
Researchers have studied possible links with sleep, stress and hormone rhythms, but its natural role remains uncertain. Evidence is mixed, so it should not be described as a proven sleep aid.
How the mechanism differs+
No single receptor or reproducible sleep mechanism has been established; rapid metabolism complicates interpretation.
Evidence and limitations+
Older small studies produced inconsistent findings, and modern controlled evidence is sparse.
Testing and batch documentation+
No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.
RESEARCH PROFILE
Understand the distinction.
Researchers have studied possible links with sleep, stress and hormone rhythms, but its natural role remains uncertain. Evidence is mixed, so it should not be described as a proven sleep aid.
No single receptor or reproducible sleep mechanism has been established; rapid metabolism complicates interpretation.
Sleep is its historical research label, but mechanistic certainty is much lower than for receptor-defined peptides.
Older small studies produced inconsistent findings, and modern controlled evidence is sparse.
Educational research context only. This information is not dosage, administration or personal-use guidance.
CONTINUE EXPLORING
Related research perspectives.
Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.
-
Experimental
Dihexa
£66.0010 mgBatch file pendingHGF/c-Met synaptogenesis hypothesis, unlike Semax’s neurotrophic ACTH-fragment lineage.
UnavailableAsk about availability -
Experimental
Pinealon
£46.0020 mgBatch file pendingA tissue-bioregulator concept with uncertain targets, unlike receptor-defined Semax or Selank research.
UnavailableAsk about availability -
Experimental
P21
£58.0010 mgBatch file pendingA CNTF-lineage neurotrophic research material whose exact sequence must be verified before meaningful comparison.
UnavailableAsk about availability -
Early human evidence
Selank
Price range: £34.99 through £52.9910 mgBatch file pendingTuftsin-derived and primarily anxiolytic/neuroimmune in focus, unlike the ACTH-derived Semax.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page